LIXTE BIOTECHNOLOGY HOLDINGS, INC. - LIXT

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$14.17M
QoQ value delta ($000)
-$433K (-2.97%)
Implied price effect (QoQ)
-0.02%
Shares
Total shares
1,921,671
QoQ shares delta
-58,309 (-2.94%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (LIXT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Legacy Wealth Managment, LLC/ID 4,456 600,669 1.84%
VANGUARD CAPITAL MANAGEMENT LLC 4,121 555,476 0.0%
SCOTIA CAPITAL INC. 2,101 283,162 0.01%
GEODE CAPITAL MANAGEMENT, LLC 1,061 143,036 0.0%
BlackRock, Inc. 563 75,958 0.0%
STATE STREET CORP 557 75,096 0.0%
VANGUARD FIDUCIARY TRUST CO 499 67,280 0.0%
Federation des caisses Desjardins du Quebec 282 38,130 0.0%
NORTHERN TRUST CORP 205 27,655 0.0%
Atlas Legacy Advisors, LLC 102 13,771 0.02%
Ethos Financial Group, LLC 99 24,808 0.01%
Equitable Holdings, Inc. 74 10,000 0.0%
UBS Group AG 47 6,400 0.0%
WELLS FARGO & COMPANY/MN 0 5 0.0%
SBI Securities Co., Ltd. 0 190 0.0%
Caitong International Asset Management Co., Ltd 0 35 0.0%